Investments
Commented by Armin Schulz on July 7th, 2026 | 07:25 CEST
Barrick Mining, Desert Gold and B2Gold – lock in the premium as risk falls
Illegal gold outflows have cost Mali billions each year, but the new Malian Office of Precious Substances is ending that era. The agency centralizes precious-metals trading, collects overdue levies and has already recovered more than USD 1 billion. For investors, this shift means transparent rules, booming official exports and, above all, falling risk. That sends the margins of compliant producers surging. We analyze how Barrick Mining is proceeding, how Desert Gold is taking the decisive step toward producer status and how B2Gold is expanding its market position.
Read
Commented by Armin Schulz on July 6th, 2026 | 07:20 CEST
Tap Into Booming Markets! Why Micron Technology, Zefiro Methane, and D-Wave Quantum Belong on The Watchlist
Retail investors who invest in structural growth trends often earn returns that leave the market well behind. The key lies not in speculation, but in the smart analysis of real economic data, from contracts to margins to operational scaling. Booming sectors are defined by sustained demand and limited supply, which have historically been strong return drivers. It is exactly this promising constellation of technological progress, regulatory tailwind and real business expansion that is currently on display at Micron Technology, Zefiro Methane and D-Wave Quantum.
Read
Commented by Stefan Feulner on July 6th, 2026 | 07:05 CEST
Lahontan Gold – Gold Explorer Poised for a Surge
Gold is currently in a correction following its record rally and is trading at around USD 4,200 per ounce. Yet more and more experts see this as merely a breather within a long-term bull market. Record debt, geopolitical conflicts, the gradual move by many central banks away from the US dollar, and persistently high gold purchases all argue for further rising prices. Gold developers on the verge of the jump to producer status should benefit in particular. With its historic mine in Nevada, numerous operational milestones, and a series of upcoming catalysts, Lahontan Gold could be facing a re-rating.
Read
Commented by Carsten Mainitz on July 3rd, 2026 | 08:15 CEST
The Spark in the Portfolio: How Milestones Unlock the True Value of Desert Gold, Siemens, and Mutares!
The stock market trades on the future. Yet a stock's most rewarding phases often begin when future promises turn into tangible milestones. Whether it is the transition to gold production in West Africa, strategic carve-outs in industry, or successful turnarounds in the private equity sector, reaching a key milestone can mark the beginning of a fundamental re-rating. In particular, the transformation from gold explorer to producer—as Desert Gold Ventures is currently pursuing—has historically been associated with higher valuations. Project-specific risks decline significantly, while the prospect of future cash flows supports a fundamentally different valuation framework. The latest developments at all three companies are noteworthy—and well worth a closer look.
Read
Commented by Jens Castner on July 3rd, 2026 | 08:10 CEST
TURNAROUND AFTER YEARS OF STRUGGLE: SOFTBANK, STRATEGIC RESOURCES, AND AIXTRON UNDER THE MICROSCOPE
SoftBank has done it. After more than two decades in the shadow of its own dot-com excesses, the Japanese technology investor is once again the most valuable company on the Tokyo Stock Exchange. Meanwhile, German semiconductor equipment manufacturer Aixtron is once again approaching its record high from 2000. Both cases demonstrate that even stocks once considered massively overvalued can stage a remarkable comeback after years of underperformance—provided they are supported by a genuine structural growth trend. This is a pattern that could also play out for Strategic Resources. The key difference is that its share price has collapsed despite never having reached the kind of extreme valuations seen in the other two cases.
Read
Commented by Nico Popp on July 2nd, 2026 | 07:40 CEST
M&A Window Opens: Newmont Needs Gold, Lahontan Has It – Optimism at Commerzbank
Gold is currently on a roller-coaster ride. But behind the scenes, declining ore grades and challenging regulatory requirements are weighing on the business of major producers. As established mining companies must replenish their reserves, advanced junior mining companies in politically stable mining regions are coming into focus. In times when economic activity is slowing in many economies, and the interest rate market is becoming more volatile, it is also worth taking a look at the banking sector.
Read
Commented by Armin Schulz on July 2nd, 2026 | 07:30 CEST
Gold Price Correction as an Opportunity: Why Barrick Mining, Kobo Resources, and B2Gold Now Offer Upside Potential
The gold price correction, which at times pushed the precious metal below the psychologically important USD 4,000 mark, may seem like a setback at first glance. In fact, it is precisely this consolidation phase that offers investors a strategic entry point. The price drop is proving to be a rigorous stress test that separates solid business models from speculative bets. While weaker players are suffering under the pressure of a weak quarter, producers with strong balance sheets and low production thresholds are now revealing clear valuation advantages. The focus is therefore shifting from pure price performance to the quality of each company's structure. We analyze the established industry leader Barrick Mining, the promising explorer Kobo Resources, and the smaller gold producer B2Gold.
Read
Commented by Nico Popp on July 1st, 2026 | 07:30 CEST
Worry-Free Dividends: Best Buy and Unilever Are Turning the Corner—RE Royalties Offers Deep Value and a 10% Dividend
War or peace? Rarely has the global situation been so chaotic. Even the AI hype, which has driven stock prices higher for years, is fading. So what should investors do? Stable income generators, such as solid dividend stocks, have always been in demand during comparable market phases. But which dividend stock is truly a good choice? While many large corporations are having to reinvent themselves, innovative players in promising niches are shaking up entire markets. A comparison of the three companies—Best Buy, Unilever, and RE Royalties—shows what matters most to dividend investors right now.
Read
Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST
AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly
Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.
Read
Commented by Matthias Schomber on June 26th, 2026 | 07:25 CEST
SAP Testing the Waters, BYD On the Offensive, and MustGrow Biologics Raises Fresh Capital - Is a Rebound on the Horizon?
Created and published on behalf of MustGrow Biologics Corp.
The winds across global equity markets have grown noticeably stronger, bringing sharp moves in both directions. Technology and automotive giants that have long been accustomed to success are feeling the full force of this turbulence. Faced with declining share prices and geopolitical uncertainty, investors are increasingly looking beyond the mainstream for fresh opportunities. While companies such as SAP and BYD are fighting to defend their lofty valuations, intriguing second-tier players are quietly positioning themselves for growth. This raises a legitimate question: should investors allocate capital into "fallen angels" such as SAP and BYD, or focus on lesser-known growth stories with potentially greater upside? We examine the current market environment and take a closer look at three very different companies. Discover why software heavyweight SAP and electric vehicle pioneer BYD are facing challenges, and why Canadian agtech company MustGrow Biologics could be approaching a breakout. One thing is certain: the stage is set for an exciting summer in the markets.
Read